BamSEC and AlphaSense Join Forces
Learn More

Atea Pharmaceuticals Inc. – Material Contracts

NASDAQ: AVIR    
Share price (4/8/26): $5.93    
Market cap (4/8/26): $472 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1(8)
from 10-K 7 pages Atea Pharmaceuticals, Inc. 2020 Incentive Award Plan Performance-Based Restricted Stock Unit Grant Notice
12/34/56
EX-10.1(7)
from 10-K 7 pages Atea Pharmaceuticals, Inc. 2020 Incentive Award Plan Performance-Based Restricted Stock Unit Grant Notice
12/34/56
EX-10.1
from 10-K 31 pages Atea Pharmaceuticals, Inc. 2020 Incentive Award Plan
12/34/56
EX-10.1
from 10-Q 43 pages License Agreement
12/34/56
EX-10.1
from 8-K 20 pages This Letter (This “Agreement”) Constitutes an Agreement by and Among (A) Atea Pharmaceuticals, Inc. (The “Company”) and (B) Bradley L. Radoff (And Together With the Radoff Family Foundation, “Radoff”) and Jec II Associates, LLC (And Together With the Mos Trust, Mos Ptc, LLC and Michael Torok, “Jec” and Collectively With Radoff, the “Radoff/Jec Signatories”). the Company and the Radoff/Jec Signatories Are Collectively Referred to as the “Parties.” the Radoff/Jec Signatories and Each Affiliate (As Defined Below) and Associate (As Defined Below) of Each Radoff/Jec Signatory Are Collectively Referred to as the “Radoff/Jec Group”. 1. Board Matters
12/34/56
EX-10.1(6)
from 10-K 7 pages Atea Pharmaceuticals, Inc. 2020 Incentive Award Plan Performance-Based Restricted Stock Unit Grant Notice
12/34/56
EX-10.1(5)
from 10-K 7 pages Atea Pharmaceuticals, Inc. 2020 Incentive Award Plan Performance-Based Restricted Stock Unit Grant Notice
12/34/56
EX-10.1
from 10-Q 4 pages Atea Pharmaceuticals, Inc. Non-Employee Director Compensation Program
12/34/56
EX-10.1(4)
from 10-K 7 pages Atea Pharmaceuticals, Inc. 2020 Incentive Award Plan Performance-Based Restricted Stock Unit Grant Notice
12/34/56
EX-10.1(3)
from 10-K 7 pages Atea Pharmaceuticals, Inc. 2020 Incentive Award Plan Performance-Based Restricted Stock Unit Grant Notice
12/34/56
EX-10.3
from 10-Q 7 pages Restricted Stock Unit Agreement
12/34/56
EX-10.2
from 10-Q 8 pages Atea Pharmaceuticals, Inc. 2020 Incentive Award Plan
12/34/56
EX-10.1
from 10-Q 6 pages Atea Pharmaceuticals, Inc. Non-Employee Director Compensation Program
12/34/56
EX-10
from 10-K 4 pages Atea Pharmaceuticals, Inc. Non-Employee Director Compensation Program
12/34/56
EX-10.2
from 10-Q 9 pages Consulting Agreement
12/34/56
EX-10.1
from 10-Q 6 pages R E C I T a L S
12/34/56
EX-10.5
from 10-K 49 pages License Agreement by and Between Msd International Gmbh and Atea Pharmaceuticals, Inc. License Agreement
12/34/56
EX-10.3
from 10-K 3 pages Atea Pharmaceuticals, Inc. Non-Employee Director Compensation Program
12/34/56
EX-10.1.2
from 10-K 7 pages Atea Pharmaceuticals, Inc. 2020 Incentive Award Plan Performance-Based Restricted Stock Unit Grant Notice
12/34/56
EX-10.1.1
from 10-K 7 pages Atea Pharmaceuticals, Inc. 2020 Incentive Award Plan Performance-Based Restricted Stock Unit Grant Notice
12/34/56